ArticleObesity surgery2026
Efficacy Analysis of Simultaneous Bariatric Surgery and Radical Thyroidectomy in Patients with Obesity and Low-Risk Papillary Thyroid Cancer: A Pilot Feasibility and Safety Study.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundObesity is an independent risk factor for various chronic diseases and malignancies. The incidence of thyroid cancer is significantly higher in obese populations. Current clinical practice often adopts staged treatment for obesity with thyroid cancer, which presents challenges including cancer management and prolonged recovery. The simultaneous implementation of bariatric surgery and radical thyroidectomy may represent a more efficient therapeutic strategy. This study evaluates the clinical value of this combined approach by comparing clinical data with standalone bariatric surgery, focusing on feasibility, safety, and comparative metabolic and weight loss efficacy.
methodsPatients who underwent laparoscopic bariatric surgery at our center from March 2015 to March 2023 were retrospectively collected. Using propensity score matching method, patients were stratified into two cohorts: the simultaneous group (SS group, n = 24) receiving combined bariatric surgery with radical thyroidectomy, and bariatric surgery group (BS group, n = 72). Surgical outcomes, complications, and 2-year follow-up data were compared.
resultsPreoperative characteristics were comparable (p > 0.05). The SS group had longer operative duration (median 242.50 vs. 104.50 min, p < 0.05) and higher blood loss (35.00 vs. 25.00 mL, p < 0.05) than the BS group, with no significant difference in short-term complications (p > 0.05). At 2 years postoperatively, the SS group reported no hypocalcemia, hypothyroidism, or cancer recurrence. Both groups achieved significant, comparable reductions in weight, body mass index, and metabolic parameters postoperatively.
conclusionsFor patients with obesity complicated by T1-T2N0M0 low-risk papillary thyroid carcinoma, this pilot study demonstrates that simultaneous bariatric surgery and radical thyroidectomy is safe and feasible, without an increased risk of complications. The efficacy of this combined approach in terms of weight loss and metabolic improvement is comparable to that of standalone bariatric surgery, highlighting its clinical application value in centers with relevant combined clinical experience.
Indexed as
Identifiers
42176159What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.